[Neutralization with naloxone of large doses of opiates in anesthesia]. 1976

L Torrado Ruiz, and J Gilabert Noguera, and J M Gutiérrez Goicoechea

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009022 Morphine Derivatives Analogs or derivatives of morphine. Morphines
D009270 Naloxone A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors. MRZ 2593-Br,MRZ-2593,Nalone,Naloxon Curamed,Naloxon-Ratiopharm,Naloxone Abello,Naloxone Hydrobromide,Naloxone Hydrochloride,Naloxone Hydrochloride Dihydride,Naloxone Hydrochloride, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Naloxone, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Narcan,Narcanti,Abello, Naloxone,Curamed, Naloxon,Dihydride, Naloxone Hydrochloride,Hydrobromide, Naloxone,Hydrochloride Dihydride, Naloxone,Hydrochloride, Naloxone,MRZ 2593,MRZ 2593 Br,MRZ 2593Br,MRZ2593,Naloxon Ratiopharm
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000758 Anesthesia A state characterized by loss of feeling or sensation. This depression of nerve function is usually the result of pharmacologic action and is induced to allow performance of surgery or other painful procedures.

Related Publications

L Torrado Ruiz, and J Gilabert Noguera, and J M Gutiérrez Goicoechea
January 1974, Anesthesia and analgesia,
L Torrado Ruiz, and J Gilabert Noguera, and J M Gutiérrez Goicoechea
January 1989, Journal of toxicology. Clinical toxicology,
L Torrado Ruiz, and J Gilabert Noguera, and J M Gutiérrez Goicoechea
September 1987, Anesthesiology,
L Torrado Ruiz, and J Gilabert Noguera, and J M Gutiérrez Goicoechea
October 1984, Lakartidningen,
L Torrado Ruiz, and J Gilabert Noguera, and J M Gutiérrez Goicoechea
January 1985, Anesteziologiia i reanimatologiia,
L Torrado Ruiz, and J Gilabert Noguera, and J M Gutiérrez Goicoechea
April 1990, Der Anaesthesist,
L Torrado Ruiz, and J Gilabert Noguera, and J M Gutiérrez Goicoechea
February 1984, British medical journal (Clinical research ed.),
L Torrado Ruiz, and J Gilabert Noguera, and J M Gutiérrez Goicoechea
August 1988, Pharmacology, biochemistry, and behavior,
L Torrado Ruiz, and J Gilabert Noguera, and J M Gutiérrez Goicoechea
July 1978, Anesthesiology,
L Torrado Ruiz, and J Gilabert Noguera, and J M Gutiérrez Goicoechea
January 1997, Przeglad lekarski,
Copied contents to your clipboard!